So the only way to get to intravenous dosing is to
Post# of 148337
I am clueless as to FDA protocols, but surely there is a better way.
Surely someone must have experienced this same problem before, an effective drug that was administered with oral or subcutaneous and then someone discoverd that it was great for emergent patients in the oral or subQ method.
Surely there is no need for a wheel reinvention here.
Although possibly a new wheel need for a pandemic environment?